# Clinical trials recruiting in Alaska: 129 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 129 trials recruiting or not yet recruiting with a site in Alaska, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Alaska: 129 rows for $6.45, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/alaska

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 129
- Recruiting or not yet: 129
- Read on: November 19, 2026

## Trials

The 25 newest of 129, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 27, 2026 | NCT07897838 | Neqpiaput Iinruugut (Our Food Is Medicine): A Tribally Driven Food Sovereignty Intervention to Reduce Heart Disease Risk in Alaska Native... | University of Alaska Fairbanks | Not applicable | Not yet recruiting | Cardiovascular (CV) Risk | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897838) |
| September 21, 2026 | NCT07829341 | Qungasvik (Toolbox)-Healthy Hearts: A Cultural Approach to Reducing Chronic Disease Risk | University of Alaska Fairbanks | Not applicable | Not yet recruiting | Cardio Vascular Disease, Cerebro Vascular Disease, Mental Health, Chronic Disease (Physical) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829341) |
| September 14, 2026 | NCT07816666 | Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer | AstraZeneca | Phase 3 | Recruiting | Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer... | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816666) |
| September 3, 2026 | NCT07801989 | Alaska Alliance for Community Engagement Phase II: Partnership for Action Toward Health | University of Alaska Fairbanks | Phase 1 | Not yet recruiting | Chronic Disease, Mental Health, Caridovascular Disease, Stress, Adolescent Health | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801989) |
| August 20, 2026 | NCT07777822 | Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous... | Revolution Medicines, Inc. | Phase 3 | Recruiting | NSCLC, Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer NSCLC, Non-Squamous Non Small Cell Lung Cancer, Lung... | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777822) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 10, 2026 | NCT07755540 | Group Music Therapy for Chronic Pain Management in Active Duty Service Members | Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 2 | Recruiting | Chronic Pain | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07755540) |
| April 13, 2026 | NCT07522073 | A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal... | Incyte Corporation | Phase 3 | Recruiting | Solid Tumors | 588 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07522073) |
| March 25, 2026 | NCT07492641 | BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not... | BeOne Medicines | Phase 3 | Recruiting | HR+/HER2- Breast Cancer | 1,056 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492641) |
| February 24, 2026 | NCT07431281 | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric... | AstraZeneca | Phase 3 | Recruiting | Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer | 2,130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07431281) |
| February 5, 2026 | NCT07388498 | A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via... | Amgen | Phase 3 | Recruiting | Uncontrolled Gout | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07388498) |
| December 16, 2025 | NCT07283939 | Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays | Alliance for Clinical Trials in Oncology | Not applicable | Recruiting | Ampulla of Vater Carcinoma, Appendix Carcinoma, Carcinoma of Unknown Primary With Gastrointestinal Profile, Colon... | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07283939) |
| November 12, 2025 | NCT07227402 | A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Renal Cell Carcinoma | 904 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07227402) |
| October 23, 2025 | NCT07220291 | YK Delta Food Box Study | Alaska Native Tribal Health Consortium | Not applicable | Recruiting | Food Insecurity | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07220291) |
| October 14, 2025 | NCT07216703 | A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Cervical Cancer | 1,023 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216703) |
| October 1, 2025 | NCT07200830 | Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate... | Alliance for Clinical Trials in Oncology | Phase 3 | Recruiting | Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC... | 1,524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07200830) |
| September 30, 2025 | NCT07198074 | Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy... | National Cancer Institute (NCI) | Phase 3 | Recruiting | Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma | 255 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07198074) |
| September 15, 2025 | NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic... | Eli Lilly and Company | Phase 3 | Recruiting | Breast Neoplasms, Neoplasm Metastasis | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07174336) |
| August 27, 2025 | NCT07144280 | A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated... | Pfizer | Phase 3 | Recruiting | Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 680 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144280) |
| August 27, 2025 | NCT07143487 | Family Communications After Genetic Testing | Alliance for Clinical Trials in Oncology | Not applicable | Recruiting | Colon Adenocarcinoma, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Stage I Colon Cancer AJCC v8, Stage I... | 4,186 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07143487) |
| August 17, 2025 | NCT07128199 | A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor... | Taiho Oncology, Inc. | Phase 3 | Recruiting | Lung Cancer, Adjuvant, Post-surgical, EGFR, Exon 20, Early Stage Lung Cancer, Uncommon EGFR Mutations, NSCLC, Early... | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07128199) |
| August 7, 2025 | NCT07108660 | Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction | Swedish Medical Center | Not applicable | Recruiting | Central Line Associated Blood Stream Infections (CLABSI) | 17,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07108660) |
| July 31, 2025 | NCT07097142 | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for... | NRG Oncology | Phase 3 | Recruiting | Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 | 486 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07097142) |
| July 29, 2025 | NCT07091617 | Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer | Alliance for Clinical Trials in Oncology | Not applicable | Recruiting | Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos | 535 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07091617) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Providence Alaska Medical Center | Anchorage | 55 |
| Alaska Women's Cancer Care | Anchorage | 47 |
| Katmai Oncology Group | Anchorage | 44 |
| Alaska Oncology and Hematology LLC | Anchorage | 41 |
| Anchorage Associates in Radiation Medicine | Anchorage | 40 |
| Alaska Breast Care and Surgery LLC | Anchorage | 40 |
| Fairbanks Memorial Hospital | Fairbanks | 34 |
| Anchorage Radiation Therapy Center | Anchorage | 30 |
| Anchorage Oncology Centre | Anchorage | 29 |
| Alaska Oncology and Hematology | Anchorage | 9 |
| Alaska Womens Cancer Care | Anchorage | 3 |
| Alaska Oncology and Hematology, LLC | Anchorage | 3 |
| University of Alaska Fairbanks | Fairbanks | 3 |
| Alaska Native Tribal Health Consortium | Anchorage | 2 |
| Yukon-Kuskokwim Health Corporation | Bethel | 2 |
| Southcentral Foundation | Anchorage | 2 |
| Alaska Oncology & Hematology, LLC | Anchorage | 2 |
| Orthopedic Physicians Alaska | Anchorage | 2 |
| Anchorage Native Primary Care Center | Anchorage | 1 |
| Bartlett Regional Hospital | Juneau | 1 |
| PeaceHealth Ketchikan Medical Center | Ketchikan | 1 |
| Yukon Kuskowkim Health Corporation | Bethel | 1 |
| Bassett Army Community Hospital | Fairbanks | 1 |
| Fairbanks Cancer Care Physicians, PC | Fairbanks | 1 |
| Alaska Women's Cancer Center | Anchorage | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 2 |
| Phase 1/2 | 1 |
| Phase 2 | 28 |
| Phase 2/3 | 6 |
| Phase 3 | 57 |
| Phase 4 | 1 |
| Not applicable | 21 |
| Observational | 13 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Lung Neoplasms | 11 |
| Breast Neoplasms | 10 |
| Ovarian Neoplasms | 7 |
| Prostatic Neoplasms | 6 |
| Urinary Bladder Neoplasms | 5 |
| Burkitt Lymphoma | 5 |
| Endometrial Neoplasms | 5 |
| Melanoma | 5 |
| Rectal Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Fallopian Tube Neoplasms | 4 |
| Heart Failure | 4 |
| Stomach Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Neoplasms | 3 |
| Colonic Neoplasms | 3 |
| Adenocarcinoma Of Esophagus | 3 |
| Multiple Myeloma | 3 |
| Leukemia, Biphenotypic, Acute | 3 |
| Carcinoma | 3 |
| Carcinoma, Renal Cell | 3 |
| Smoking Cessation | 2 |
| Brain Neoplasms | 2 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 15 |
| SWOG Cancer Research Network | 14 |
| Alliance for Clinical Trials in Oncology | 12 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 9 |
| ECOG-ACRIN Cancer Research Group | 8 |
| Children's Oncology Group | 7 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 5 |
| NRG Oncology | 5 |
| Alaska Native Tribal Health Consortium | 3 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 3 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 3 |
| University of Alaska Fairbanks | 3 |
| Southcentral Foundation | 2 |
| Mayo Clinic | 2 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 2 |
| Eastern Cooperative Oncology Group | 2 |
| Canadian Cancer Trials Group | 2 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 2 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 2 |
| [Gilead Sciences](https://specstream.ai/data/clinical-trials/company/gilead-sciences) | 1 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 1 |
| [Taiho Oncology, Inc.](https://specstream.ai/data/clinical-trials/company/taiho-oncology-inc) | 1 |
| Brooke Army Medical Center | 1 |
| Swedish Medical Center | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Alaska

- [Construction companies in Alaska, United States](https://specstream.ai/data/businesses/construction-companies/alaska-united-states)
- [Law firms in Alaska, United States](https://specstream.ai/data/businesses/law-firms/alaska-united-states)
- [Specialty schools in Alaska, United States](https://specstream.ai/data/businesses/specialty-schools/alaska-united-states)
- [Commercial real estate firms in Alaska, United States](https://specstream.ai/data/businesses/commercial-real-estate-firms/alaska-united-states)
- [Landscaping companies in Alaska, United States](https://specstream.ai/data/businesses/landscaping-companies/alaska-united-states)
- [Software development companies in Alaska, United States](https://specstream.ai/data/businesses/software-development-companies/alaska-united-states)
